In vivo data showed that there was no difference in the tumor growth of subcutaneously inoculated CD248 knockdown or control SJSA-1-luc xenografts, as shown by the similar fluorescence signals examined by BLI, tumor growth curve and tumor volume (Fig. 2C-F). Here, CD248 is linked to neoplasm.